Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (311-320 of 1,126) with videos related to

Pageof 113
Sort By:
BJU International|May 30, 2007
Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancerIsmaël H Koumakpayi, Jean-Simon Diallo, Cécile Le Page, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 23, 2018
Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statementLaurence Klotz, Bobby Shayegan, Chantal Guillemette, et al.
Journal of Surgical Oncology|September 29, 2019
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladderStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Cancer|February 6, 2009
Radical versus partial nephrectomy: effect on overall and noncancer mortalityLaurent Zini, Paul Perrotte, Umberto Capitanio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2024
Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE StudySoumyajit Roy, Fred Saad, Christopher J D Wallis, et al.
Clinical Genitourinary Cancer|February 15, 2020
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United StatesDaniel J George, Oliver Sartor, Kurt Miller, et al.
JAMA Network Open|June 15, 2021
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical TrialAntonio Finelli, Tomasz M Beer, Simon Chowdhury, et al.
Clinical Genitourinary Cancer|August 17, 2019
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate CancerSophie Knipper, Angela Pecoraro, Carlotta Palumbo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkersShahrokh F Shariat, Jose A Karam, Jochen Walz, et al.
Urologic Oncology|August 18, 2015
Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: results from the North-American case-control study Prostate Cancer & Environment StudyKatharina Boehm, Maxine Sun, Alessandro Larcher, et al.
Pageof 113

Showing results (311-320 of 1,126) with videos related to

Sort By:
Pageof 113
BJU International|May 30, 2007
Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancerIsmaël H Koumakpayi, Jean-Simon Diallo, Cécile Le Page, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 23, 2018
Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statementLaurence Klotz, Bobby Shayegan, Chantal Guillemette, et al.
Journal of Surgical Oncology|September 29, 2019
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladderStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Cancer|February 6, 2009
Radical versus partial nephrectomy: effect on overall and noncancer mortalityLaurent Zini, Paul Perrotte, Umberto Capitanio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2024
Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE StudySoumyajit Roy, Fred Saad, Christopher J D Wallis, et al.
Clinical Genitourinary Cancer|February 15, 2020
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United StatesDaniel J George, Oliver Sartor, Kurt Miller, et al.
JAMA Network Open|June 15, 2021
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical TrialAntonio Finelli, Tomasz M Beer, Simon Chowdhury, et al.
Clinical Genitourinary Cancer|August 17, 2019
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate CancerSophie Knipper, Angela Pecoraro, Carlotta Palumbo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkersShahrokh F Shariat, Jose A Karam, Jochen Walz, et al.
Urologic Oncology|August 18, 2015
Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: results from the North-American case-control study Prostate Cancer & Environment StudyKatharina Boehm, Maxine Sun, Alessandro Larcher, et al.
Pageof 113